Isomorphic Labs

DeepMind spinout using AI for drug discovery

4.5

Pricing

Enterprise

About Isomorphic Labs

Isomorphic Labs is an AI drug discovery company spun out of Google DeepMind, applying AlphaFold-class models to predict protein structures and design novel therapeutics. It partners with pharmaceutical companies including Eli Lilly and Novartis to accelerate the drug development pipeline using foundation models trained on biological data.

Key Features

AI protein structure prediction
Drug candidate design and optimization
Pharmaceutical company partnerships
AlphaFold-derived foundation models
Clinical pipeline acceleration

Pros & Cons

Pros

+ World-class AI research pedigree from DeepMind

+ Major pharma partnerships validate approach

+ Potential to dramatically reduce drug discovery timelines

Cons

- Not accessible to individual researchers or startups

- Long timelines before clinical impact visible

- Highly specialized — not a general AI tool

Use Cases

Pharmaceutical drug candidate identificationProtein structure prediction for researchAccelerating preclinical drug development